Komori
General Meetings of Shareholders7096StemCell InstituteInformation and Communications, Services and Others

Notice of Convocation of the 27th Annual General Meeting of Shareholders and Shareholder Meeting Materials

At the 27th Annual General Meeting of Shareholders, the Company will submit proposals for the election of 4 directors and 1 substitute Audit & Supervisory Board Member, as well as the issuance of stock options to directors, employees and others.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
176400
Shares (maximum number of shares underlying the stock acquisition rights)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (27th fiscal year)
2026
Jun 24
Date and time(Wednesday), 3:00 p.m. (reception opens at 2:30 p.m.)24 days from this disclosure to the meeting
Matters for resolution3 items
  1. Election of 4 Directors

  2. Election of 1 substitute Audit & Supervisory Board member

  3. Issuance of stock acquisition rights as stock options to the Company's directors, executive officers and employees, and employees of the Company's subsidiaries

Shareholder Proposal

There is no statement that there are no shareholder proposals; only company proposals are listed.

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
4Nominees
1New
2Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (27th fiscal year)
Date and time24 June 2026 (Wednesday), 3:00 p.m. (reception opens at 2:30 p.m.)
Matters for resolutionProposal No. 1: Election of 4 Directors, Proposal No. 2: Election of 1 substitute Audit & Supervisory Board member, Proposal No. 3: Issuance of stock acquisition rights as stock options to the Company's directors, executive officers and employees, and employees of the Company's subsidiaries
Shareholder ProposalThere is no statement that there are no shareholder proposals; only company proposals are listed.
Director nominee4 candidates, including 1 new candidate and 2 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To enhance the motivation and morale of directors, executive officers, employees and others to improve performance, secure talented personnel and contribute to the enhancement of corporate value. As directors' compensation, to enhance their motivation to improve performance and corporate value and promote business operations that place emphasis on shareholder interests.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 27th Annual General Meeting of Shareholders and Shareholder Meeting Materials | StemCell Institute (7096) timely disclosure | Komori